Maturitas
Volume 60, Issue 3 , Pages 235-238, July 2008

The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids

Department of Gynecology, Federal University of São Paulo – UNIFESP, Rua dos Otonis, 601, Vila Clementino 040625-001, São Paulo, Brazil

Received 20 February 2008; received in revised form 9 July 2008; accepted 10 July 2008. published online 11 August 2008.

Abstract 

Objective

To assess the possible association between the catechol-O-methyltransferase (COMT) polymorphism and uterine fibroids in Brazilian women.

Design

Case-control study.

Setting

Department of Gynecology; teaching hospital.

Patient(s)

One hundred twenty-four premenopausal women with fibroids, and 193 postmenopausal controls not presenting the disease.

Intervention(s)

The subjects were classified as white or non-white (black and mulatto), and COMT genotypes were determined. DNA was extracted from the uterus of cases and from peripheral blood of controls and submitted to polymerase chain reaction (PCR) and agarose gel electrophoresis.

Main outcome measure(s)

The presence of the COMT polymorphism was recorded for all patients, and the frequency and distribution among cases and controls were compared according to race. Binomial log regression models were used to estimate odds-ratios (OR) for uterine volumes of <290cm3 (small fibroids) vs. those >290cm3 (large fibroids). Potential confounding variables (age, race and parity) were added to the model.

Results

Genotypes positive for the COMT polymorphism (heterozygous or mutant homozygous) were found in 45% of white and 28.9% of non-white women (p=.013) and the polymorphic allele frequencies in these groups were 27.2% and 16.3%, respectively (p=.006). However, there were no clear differences between patients and controls within the white subgroup with regard to the presence of COMT polymorphism-containing genotypes (41.5% vs. 46.0%, respectively) (p=.60), or for the polymorphic allele frequency (26.8% vs. 27.3%, respectively) (p=.92). For non-white women, there were also no differences between cases and controls for the frequency of polymorphic genotypes (28.9% vs. 28.9%, respectively) (p=.995), or for the polymorphic allele frequency (17.8 vs. 14.5, respectively) (p=.565).

Estimated OR for small or large fibroids in association with the polymorphic allele revealed a positive association between the allele with lower activity and large fibroids (vs. small) (OR=3.3; 95% confidence interval [CI]=1.31–8.46). The adjusted OR was 4.35 (95% confidence interval [CI]=1.58–11.9).

Conclusions

The catechol-O-methyltransferase polymorphism is a risk factor for the development of large uterine fibroids in Brazilian women suffering from fibroids.

Keywords: Uterine fibroids, Uterine leiomyoma, Risk factors, Catechol-O-methyltransferase, Polymorphism

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(08)00199-0

doi:10.1016/j.maturitas.2008.07.001

Maturitas
Volume 60, Issue 3 , Pages 235-238, July 2008